Home » Archive

News

News, Syndication »

Arena Pharmaceuticals, Inc. Says Eisai Company, Ltd. Will Double BELVIQ® Sales Force by December

Posted by sandiegobiotech October 15th, 2013 .
No Comments

Arena isn’t the only one hiring, others are hiring too! Check it out! (Isn’t it tempting?)Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ (lorcaserin HCl) CIV Sales Force by DecemberSAN DIEGO, Oct. 15, 2013

More...

News, Syndication »

Hervey family gives $1 million to advance melanoma treatment

Posted by sandiegobiotech October 14th, 2013 .
No Comments

Ze’ev Ronai, Ph.D., professor and scientific director of Sanford-Burnham in La Jolla

More...

News, Syndication »

New Strategy to Treat Multiple Sclerosis Shows Promise in Mice

Posted by sandiegobiotech October 14th, 2013 .
No Comments

The findings from the Lairson, Lawson and Schultz labs point the potential new use of an existing drug.

More...

News, Syndication »

Celladon Corp. Plans $86.3M IPO

Posted by sandiegobiotech October 14th, 2013 .
No Comments

With aims to raise $86.3 million in an initial public offering, San Diego-based Celladon Corp. has joined the bevy of biotechs aiming to go public this year.

More...

News, Syndication »

The $100M Club: Where the Major League Life Sciences Companies Are

Posted by sandiegobiotech October 14th, 2013 .
No Comments

[Updated: 1:15 pm PT 11/10] People love to rank U.S. biotech clusters. Most of these reports are full of data on venture financing, patents, jobs, and NIH funding. But many are riddled with flawed…

[[Click headline to continue reading.]]

More...

News, Syndication »

Horacio Valeiras and Bernard Saint-Donat Elected to TSRI Board of Trustees

Posted by sandiegobiotech October 14th, 2013 .
No Comments

“Their deep financial and business experience will be invaluable to Scripps as we chart our future course,” says TSRI President and CEO Michael A. Marletta.

More...

News, Syndication »

Scientists Invent a Better Way to Make Antibody-Guided Therapies

Posted by sandiegobiotech October 14th, 2013 .
No Comments

The new technique from the Barbas lab allows drug developers to forge more stable antibody-drug candidates.

More...

News, Syndication »

Team Identifies Potential New Drug for Inherited Cancer

Posted by sandiegobiotech October 14th, 2013 .
No Comments

The new study from the Kissil lab showed a drug candidate slowed the proliferation and progression of a specific type of tumor cell.

More...

News, Syndication »

Scientists identify a new component of weaponry that silences genes

Posted by sandiegobiotech October 11th, 2013 .
No Comments

Rui and Xiong revealed how SmD1—a messenger RNA (mRNA) processing protein—is a required component of RNAi.

More...

News, Syndication »

Taking A Mindful Approach to the BRAIN Initiative

Posted by sandiegobiotech October 10th, 2013 .
No Comments

As the epicenter of scientific innovation, California must take bold and prompt action to capitalize on the short- and long-term benefits of the BRAIN Initiative,” said Senate Majority Leader Ellen M. Corbett (D-East Bay) at a Senate Select Committee on Emerging Technology: Biotechnology and Green Energy Jobs public hearing held Friday at UC San Diego.

More...